, and 55 ( 20, 25, 28, 3 1, 33, 36, 52, 55, and 56) . For example, patients 5, 12, 13, 20, 25, 31, 33, 36, 52, and 56 with an absence of long-term For personal use only. on April 18, 2017. by guest www.bloodjournal.org From respectively) ( Fig 2B) . In the large FAB subgroups studied (RARS, RA, RAEB), early and late differences in survival were statistically significant only when RARS was compared with RAEB alone (P = .05 and .005, respectively).
No significant difference was observed, however, when the three groups were compared with one another (P = . I and .07, respectively) (Fig 2A) . when they were at the RAEB-T stage ( Table  2) .
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